RNA Breakthrough Offers Hope for Thousands of Untreatable Diseases
Researchers at University of Toronto, University Health Network and SickKids develop engineered tRNA as a potential RNA therapeutic platform for thousands of untreatable diseases.
Genetic Disorders | 31/08/2026 | By News Bureau
Regel Therapeutics Names Stephen J. Farr as New CEO
Regel Therapeutics’ Board of Directors has named Stephen J. Farr, PhD, as the new Chief Executive Officer (CEO).
Genetic Disorders | 21/06/2024 | By Aishwarya | 483
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy